Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 15, 2023 14:00 ET | Source: Imunon, Inc.

IMUNON Announces Abstract Accepted for Presentation at the American Association for Cancer Research Annual Meeting

LAWRENCEVILLE, N.J., March 15, 2023 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug development company, today announced that an abstract related to the Company’s DNA-based...